Abstract:Transmembrane signaling is a critical process by which changes in the extracellular environment are relayed to intracellular systems that induce changes in homeostasis. One family of intracellular systems are the guanine nucleotide exchange factors (GEFs), which catalyze the exchange of GTP for GDP bound to inactive guanine nucleotide binding proteins (G proteins). The resulting active G proteins then interact with downstream targets that control cell proliferation, growth, shape, migration, adhesion, and transcription. Dysregulation of any of these processes is a hallmark of cancer. The Dbl family of GEFs activates Rho family G proteins, which, in turn, alter the actin cytoskeleton and promote gene transcription. Although they have a common catalytic mechanism exercised by their highly conserved Dbl homology (DH) domains, Dbl GEFs are regulated in diverse ways, often involving the release of autoinhibition imposed by accessory domains. Among these domains, the pleckstrin homology (PH) domain is the most commonly observed and found immediately C-terminal to the DH domain. The domain has been associated with both positive and negative regulation. Recently, some atomic structures of Dbl GEFs have been determined that reemphasize the complex and central role that the PH domain can play in orchestrating regulation of the DH domain. Here, we discuss these newer structures, put them into context by cataloging the various ways that PH domains are known to contribute to signaling across the Dbl family, and discuss how the PH domain might be exploited to achieve selective inhibition of Dbl family RhoGEFs by small-molecule therapeutics. SIGNIFICANCE STATEMENT Dysregulation via overexpression or mutation of Dbl family Rho guanine nucleotide exchange factors (GEFs) contributes to cancer and neurodegeneration. Targeting the Dbl homology catalytic domain by small-molecule therapeutics has been challenging due to its high conservation and the lack of a discrete binding pocket. By evaluating some new autoinhibitory mechanisms in the Dbl family, we demonstrate the great diversity of roles played by the regulatory domains, in particular the PH domain, and how this holds tremendous potential for the development of selective therapeutics that modulate GEF activity.

Understanding P-Rex regulation: structural breakthroughs and emerging perspectives

Uncovering Modes of P-Rex2 Regulation to Inform Drug Design

GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors

Rho GTPases in cell biology

The RHO Family GTPases: Mechanisms of Regulation and Signaling

Identification of a Novel Guanine Nucleotide Exchange Factor for the Rho GTPase

RhoA regulation in space and time

Small-molecule inhibitors of P-Rex guanine-nucleotide exchange factors

Structural and dynamic changes in P-Rex1 upon activation by PIP3 and inhibition by IP4

New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors

Interaction between Rho GTPases and 14-3-3 Proteins

Structural and dynamic changes in P-Rex1 upon activation by PIP and inhibition by IP

Coupling of Rho family GTPases during mesenchymal-to-epithelial-like transitions

Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP

A Rab-bit hole: Rab40 GTPases as new regulators of the actin cytoskeleton and cell migration

Rho GTPases: Regulation and roles in cancer cell biology

Rho and Rac Take Center Stage

Transient Structural Properties of the Rho GDP‐Dissociation Inhibitor

The role of the Rho family small GTPases in regulation of normal and pathological processes

Rho signaling research: history, current status and future directions

Rho GTPase signaling complexes in cell migration and invasion